Arrowhead Pharmaceuticals Corp (ARWR) Misses Q1 EPS by 2c

February 9, 2018 4:00 PM

Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) reported Q1 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.51 million versus the consensus estimate of $7.27 million.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Corp (ARWR) click here.

Categories

Earnings Guidance

Next Articles